Building bridges along the psychiatric drug discovery pipeline #2

23 November 2021

Trigger warning: This webinar contains a personal account of mental health struggles, including references to suicide, which some viewers may find distressing.

If you are affected by any of the issues raised in this webinar, please visit our partner; MQ Mental Health for resources and support.

This is the second instalment of a 5-part webinar series between the British Neuroscience Association and the Psychiatry Consortium.

Psychiatric drug discovery must be a truly collaborative process if it is to be successful. All too often industry and academia work exclusively, developing transformative work in isolation of each other and only building alliances at a later stage when necessary. Cross-disciplinary partnerships cultivated earlier in the process can take a project in a whole new direction, for the benefit of those working on the science, for the patient and the investor.

This webinar took place on Tuesday 23rd November, 1-2pm (GMT) and explored how we better understand patient unmet need and feed this into drug discovery efforts.

Host organisations: BNA and Psychiatry Consortium
Guests organisation: Royal College of Psychiatrists
Chair: Subodh Dave (Dean of the Royal College of Psychiatrists)
Speakers: Simon Rose (NHS Foundation Trust), Trudi Seneviratne (Royal College of Psychiatrists)